Paul Voss, based in United States, is currently a Senior Vice President, Market Access (Allogeneic Cell Therapy - Duchenne Muscular Dystrophy) at Capricor Therapeutics, Inc.. Paul Voss brings experience from previous roles at Osprey BioPharma Strategies, LLC., Rezolute, Inc., Reneo Pharmaceuticals and Marinus Pharma. Paul Voss holds a Oregon State University. With a robust skill set that includes HEOR, Communication Training, Presentations, Commercialization, Biotechnology and more. Paul Voss has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Paul Voss?
Find contact details for 700 million professionals.